Samsung Life Insurance Special Account Slightly Sells Samsung Biologics Shares; No Change in Major Shareholder Stake
- Total shares held by major shareholders (Samsung C&T, Samsung Electronics, Samsung Life Insurance Special Account, executives) are 34,396,950 shares (74.31% stake), a decrease of 1,835 shares from the previous report, but the stake percentage unchanged.
- Samsung Life Insurance (Special Account) net sold approximately 1,835 shares through open market transactions during April 6-30, 2026, reducing its holdings to 14,206 shares.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Report on Change in Ownership of Major Shareholders, etc.
- Company: Samsung Biologics (207940)
- Submission: Samsung Biologics Co., Ltd.
- Receipt: 05-04-2026
- Under KRX KOSPI Market Division